Mark Wexman

511 total citations
7 papers, 351 citations indexed

About

Mark Wexman is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mark Wexman has authored 7 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 3 papers in Surgery and 1 paper in Pediatrics, Perinatology and Child Health. Recurrent topics in Mark Wexman's work include Cardiac Arrhythmias and Treatments (2 papers), Atrial Fibrillation Management and Outcomes (2 papers) and Lanthanide and Transition Metal Complexes (1 paper). Mark Wexman is often cited by papers focused on Cardiac Arrhythmias and Treatments (2 papers), Atrial Fibrillation Management and Outcomes (2 papers) and Lanthanide and Transition Metal Complexes (1 paper). Mark Wexman collaborates with scholars based in United States, Italy and Germany. Mark Wexman's co-authors include Anthony J. Grieco, Gerald E. Gaull, Ephraim Glassman, Arthur C. Fox, Frederick Feit, Walid I. Saliba, David O. Martin, Robert A. Schweikert, Andrea Natale and Mandeep Bhargava and has published in prestigious journals such as Journal of the American College of Cardiology, American Journal of Kidney Diseases and Journal of Cardiovascular Electrophysiology.

In The Last Decade

Mark Wexman

7 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Wexman United States	7	211	100	67	35	29	7	351
Niranjan Seshadri United States	11	339 1.6×	54 0.5×	179 2.7×	56 1.6×	63 2.2×	19	452
Yuan‐Ning Xu China	13	342 1.6×	40 0.4×	76 1.1×	143 4.1×	48 1.7×	26	460
Santhosh Jay Mathews United States	8	160 0.8×	22 0.2×	98 1.5×	65 1.9×	57 2.0×	14	300
Jan‐Dierk Clausen Germany	10	126 0.6×	21 0.2×	158 2.4×	45 1.3×	28 1.0×	41	394
J.C. Burnett United States	5	255 1.2×	15 0.1×	37 0.6×	84 2.4×	53 1.8×	10	519
Stephan Hornykewycz Austria	11	93 0.4×	22 0.2×	85 1.3×	47 1.3×	10 0.3×	25	293
Martinson Arnan United States	9	97 0.5×	20 0.2×	130 1.9×	103 2.9×	14 0.5×	9	355
T. B. Counihan United Kingdom	10	122 0.6×	14 0.1×	51 0.8×	152 4.3×	19 0.7×	24	446
David C. Wymer United States	6	44 0.2×	23 0.2×	60 0.9×	24 0.7×	48 1.7×	18	436
Laura Montagna Italy	9	227 1.1×	26 0.3×	63 0.9×	75 2.1×	14 0.5×	12	375

Countries citing papers authored by Mark Wexman

Since Specialization

Citations

This map shows the geographic impact of Mark Wexman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Wexman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Wexman more than expected).

Fields of papers citing papers by Mark Wexman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Wexman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Wexman. The network helps show where Mark Wexman may publish in the future.

Co-authorship network of co-authors of Mark Wexman

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Wexman. A scholar is included among the top collaborators of Mark Wexman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Wexman. Mark Wexman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Strunk, Brian L., et al.. (2006). High incidence of focal left ventricular wall motion abnormalities and normal coronary arteries in patients with myocardial infarctions presenting to a community hospital.. PubMed. 18(8). 376–81. 15 indexed citations

Wazni, Oussama M., Antonio Rossillo, Nassir Marrouche, et al.. (2005). Embolic Events and Char Formation During Pulmonary Vein Isolation in Patients with Atrial Fibrillation: Impact of Different Anticoagulation Regimens and Importance of Intracardiac Echo Imaging. Journal of Cardiovascular Electrophysiology. 16(6). 576–581. 107 indexed citations

Khaykin, Yaariv, Nassir F. Marrouche, David O. Martin, et al.. (2004). Pulmonary Vein Isolation for Atrial Fibrillation in Patients with Symptomatic Sinus Bradycardia or Pauses. Journal of Cardiovascular Electrophysiology. 15(7). 784–789. 34 indexed citations

Viquerat, Christian E., Dean J. Kereiakes, Danielle Morris, et al.. (1985). Alterations in left ventricular function, coronary hemodynamics and myocardial catecholamine balance with MDL 17043, a new inotropic vasodilator agent, in patients with severe heart failure. Journal of the American College of Cardiology. 5(2). 326–332. 45 indexed citations

Wexman, Mark, Anthony J. Grieco, Ephraim Glassman, et al.. (1985). Methionine intolerance: A possible risk factor for coronary artery disease. Journal of the American College of Cardiology. 6(4). 725–730. 117 indexed citations

Morris, Danielle, et al.. (1985). Potentiation by nifedipine and diltiazem of the hypotensive response after contrast angiography. Journal of the American College of Cardiology. 6(4). 785–791. 14 indexed citations

Papadakis, Maxine A., Mark Wexman, C. L. Fraser, & Scot Sedlacek. (1985). Hyperkalemia Complicating Digoxin Toxicity in a Patient With Renal Failure. American Journal of Kidney Diseases. 5(1). 64–66. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact